Hip Replacement Market forecast 2019-2026

 In 2018, the global hip replacement market was valued at USD 5.56 billion, and it is expected to increase at a CAGR of 4.7 percent over the forecast period. Increased demand for hip arthroplasty/replacement surgical treatments, as well as an increase in the senior population and the high frequency of lower extremity illnesses such as osteoarthritis (OA), osteoporosis, and hip problems, are all important growth drivers. According to a survey published by the Osteoarthritis Research Society International, over 130 million individuals worldwide would be affected by OA by 2050.



The prevalence of cheap healthcare facilities in developed countries, as well as technical breakthroughs in non-invasive surgeries, are projected to propel the industry forward. Non-metal materials, such as polymer and ceramic, are expected to assist solve issues with traditional devices, such as increased metallic ions in the bloodstream of patients and implant deterioration with time. The newer operating techniques have shortened hospital stay post full hip replacement surgery to less than 4 days.

Furthermore, the rising number of younger people suffering from degenerative diseases is predicted to boost income during the projection period. Furthermore, a boost in the number of robot-assisted operations has increased the success rate of minimally invasive surgeries, which is expected to generate profitable growth opportunities for this market in the near future.

Favorable reimbursement policies are helping to enhance growth even more. According to the Patient Protection and Affordable Care Act (PPACA), insurance coverage for orthopedic devices has increased, making them more accessible to a wider range of patients. Both governmental (e.g., CMS) and private payers have begun to provide adequate coverage for prosthetics and orthotics in recent years.



For example, Johnson & Johnson launched an “India centric” payment policy in November 2018, guaranteeing complete reimbursement for patients who need revision surgery within 15 years of their first hip replacement operation. 

In August 2018, Conformis, Inc., a medical technology company, worked with JFK Medical Center in Florida to perform first 3D total hip replacement surgery.

Product Insights

Total hip implants, partial femoral head, hip resurfacing, and revision hip are the goods that make up the market. Because of the increased desire for minimally invasive surgeries and continued technological improvements, total hip implants held the greatest market share in 2018. Furthermore, the rising prevalence of osteoarthritis is a major market driver..In 2016, 90 percent of complete hip replacements in the United Kingdom were performed for osteoarthritis, according to the National Joint Registry for England.


Players in the business are constantly working to develop new technologies and navigation systems in order to simplify surgical operations and expand their market share. Conformis, Inc., for example, teamed with JFK Medical Center in Florida to perform the first-ever 3D total hip replacement operation in August 2018. In May of this year, OrthoAlign, Inc. released the HipAlign app, which offers sophisticated guidance technology during surgery.

Hip resurfacing surgery also accounted for a sizable portion of the Hip Replacement Market. Instead of total replacement, these implants help straighten damaged joints. They can be used as a replacement for a total hip replacement. Many major players are investing in R&D to develop novel ceramic implants that will improve patient outcomes. For example, a clinical trial on a ceramic device implant called "H1" is now underway, with the goal of achieving a quicker recovery time than whole hip implants.

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market